Op2Lysis won the Special Prize at Biovision Forum 2017

Op2Lysis won the Special Prize at Biovision Forum 2017

Op2Lysis received the “Catalyzer” Special Prize at the Biovision Forum in Lyon, France, on Thursday, April 6. Christophe Gaudin, co-founder of Op2Lysis, could convince the jury to honor Op2Lysis, based on our ambition of developing the first medical treatment for hemorrhagic stroke patients (a form which affects 10 to 15% of stroke patients), and on the potential and quality of our technology.

More information on the laureates and on the Biovision forum is available at http://www.biovision.org/catalyzer-winners.php

About the author

Tiffany Le Carff administrator